یکشنبه 18 خرداد 1404
[Archive]
دوره 11، شماره 42 - ( فروردين 1382 )
جلد 11 شماره 42 صفحات 37-31 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Marashinezhad S A, Bassampour S A. The Use Of Bioglass In The Treatment Of Benign Bone Tumors And Nonunion Bone Fractures After Surgery. J Adv Med Biomed Res 2003; 11 (42) :31-37
URL: http://journal.zums.ac.ir/article-1-23-fa.html
URL: http://journal.zums.ac.ir/article-1-23-fa.html
مرعشی نژاد سیدعلی، بصام پور سیدعلیرضا. استفاده از بیوگلاس ها در درمان تومورهای خوش خیم استخوان و شکستگی های جوش نخورده پس از عمل جراحی در سال 81ـ1380 در بیمارستان امام خمینی اهواز. Journal of Advances in Medical and Biomedical Research. 1382; 11 (42) :31-37
چکیده: (156599 مشاهده)
Introduction: Bone grafting has been recommended in various clinical problems such as nonunion fractures after surgery, fixation of fractures, filling remaining cavities in bones after debridement and curtage in osteomyelitis and tumors. The use of Bioglass material are recommended by manufacturers when bone grafting is not possible. In this investigation, the use of Nova bone (Bioglass) was studied on the treatment of benign tumors and nonunion fractures after surgery.
Materials and Methods: In this case series study 14 patients with bone tumors and 2 patients with nonunion fracture were studied over one year period. All bone tumors were benign and consisted of 3 cases of nonossifying fibroma (N.O.F), 3 cases of anurismal bone cyst (A.B.C.), 2 cases of unicameral bone cyst (U.B.C), one case of ossifying fibroma and 5 cases of giant call tumors (G.C.T).
Results: Unpredictable clinical complications were not seen in any of the cases. The average recovery time for benign tumors after nova bone grafting was 3 months and for nonunion fractures was 6 months. Recurrence were occurred in all cases of giant cell tumors.
Conclusion: Nova bone is appropriate for use in benign tumors of bone, but we do not recommend it in the treatment of patients with malignant or sometimes malignant tumors of bone such as giant cell tumors.
Materials and Methods: In this case series study 14 patients with bone tumors and 2 patients with nonunion fracture were studied over one year period. All bone tumors were benign and consisted of 3 cases of nonossifying fibroma (N.O.F), 3 cases of anurismal bone cyst (A.B.C.), 2 cases of unicameral bone cyst (U.B.C), one case of ossifying fibroma and 5 cases of giant call tumors (G.C.T).
Results: Unpredictable clinical complications were not seen in any of the cases. The average recovery time for benign tumors after nova bone grafting was 3 months and for nonunion fractures was 6 months. Recurrence were occurred in all cases of giant cell tumors.
Conclusion: Nova bone is appropriate for use in benign tumors of bone, but we do not recommend it in the treatment of patients with malignant or sometimes malignant tumors of bone such as giant cell tumors.
نوع مطالعه: مقاله پژوهشی |
دریافت: 1385/6/15 | پذیرش: 1396/3/28 | انتشار: 1396/3/28
دریافت: 1385/6/15 | پذیرش: 1396/3/28 | انتشار: 1396/3/28
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
